Request Information

View Our Results for Parkinson's Disease

Celltex conducted a registry study based on the reported results of our clients with Parkinson’s disease (PD).

The study utilized a number of survey methods to assess the reported results of clients with PD who received MSC therapy between March 2012 and December 2020.

Complete the form below to receive a detailed overview of our reported results for PD.